In human cancers, aberrant methylation of VIM has been shown in colorectal cancer [34], gastric cancer [35], bladder cancer [36], pancreatic cancer [37], cervical cancer [38] and breast cancer [39]. Here, VIM is linked to urinary bladder cancer.